OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
640058

Fuji Seiki Co Ltd

Industrial Machinery & EquipmentVerified

Fuji Seiki maintains a debt-to-equity ratio of 1.01, indicating a balanced capital structure with moderate leverage. The company's liquidity position is characterized as medium risk, with a current ratio of 1.39, suggesting it can cover short-term obligations but with limited buffer. Free cash flow stands at 136.6 million JPY, which is lower than operating cash flow of 927.9 million JPY, reflecting capital expenditures of 625.4 million JPY in the latest period. Profitability metrics show a return on equity of 6.23% and a return on assets of 2.36%. These figures are below the industry median for ROE and ROA in the Industrial Machinery & Equipment sector, indicating that Fuji Seiki is underperforming in asset utilization and shareholder returns relative to its peers. Gross profit of 1.8 billion JPY represents 20.6% of revenue, which is in line with industry norms but leaves room for improvement in operating margins, which stand at 4.87% of revenue. The company operates in two business segments: Precision Molds For Injection Molding and Injection Molding System, and Precision Molding and Others. Revenue concentration data is not available in the input, but the dual-segment structure suggests diversification within the industrial goods space. No geographic breakdown is provided, but the company is based in Japan, and its operations are likely concentrated in the Asia-Pacific region. Outlook data is not provided in the input, but the company's revenue of 8.72 billion JPY in the latest period suggests a stable base. The absence of forward-looking guidance makes it difficult to assess growth trajectory, but the capital expenditure of 625.4 million JPY indicates ongoing investment in operations. The company's free cash flow is positive but modest, which may limit its ability to fund aggressive expansion. Risk factors include a medium liquidity risk and a key flag of negative net cash after subtracting total debt. The dilution risk is assessed as low, with no near-term pressure expected. The company's capital structure is stable, with long-term debt of 3.76 billion JPY and cash and equivalents of 1.87 billion JPY. No dilution sources are explicitly cited in the input, but the low dilution risk suggests no imminent equity issuance. Recent events include the latest financial filing, which shows a net income of 230.8 million JPY and an EPS of 28.50 JPY. No recent transcripts or filings beyond the financial snapshot are provided in the input, so no additional commentary on management guidance or strategic shifts is available.

30-day price · 6400+1.00 (+0.4%)
Low$270.00High$296.00Close$276.00As of21 May, 00:00 UTC
Profile
CompanyFuji Seiki Co Ltd
Ticker6400.T
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryIndustrial Machinery & Equipment
AI analysis

Business. Fuji Seiki Co Ltd designs and sells precision molds for injection molding and injection molding systems, primarily serving the industrial goods sector.

Classification. Fuji Seiki is classified under the Industrial Machinery & Equipment industry within the Industrials sector, with a confidence level of 0.92 based on verified market data.

Fuji Seiki maintains a debt-to-equity ratio of 1.01, indicating a balanced capital structure with moderate leverage. The company's liquidity position is characterized as medium risk, with a current ratio of 1.39, suggesting it can cover short-term obligations but with limited buffer. Free cash flow stands at 136.6 million JPY, which is lower than operating cash flow of 927.9 million JPY, reflecting capital expenditures of 625.4 million JPY in the latest period. Profitability metrics show a return on equity of 6.23% and a return on assets of 2.36%. These figures are below the industry median for ROE and ROA in the Industrial Machinery & Equipment sector, indicating that Fuji Seiki is underperforming in asset utilization and shareholder returns relative to its peers. Gross profit of 1.8 billion JPY represents 20.6% of revenue, which is in line with industry norms but leaves room for improvement in operating margins, which stand at 4.87% of revenue. The company operates in two business segments: Precision Molds For Injection Molding and Injection Molding System, and Precision Molding and Others. Revenue concentration data is not available in the input, but the dual-segment structure suggests diversification within the industrial goods space. No geographic breakdown is provided, but the company is based in Japan, and its operations are likely concentrated in the Asia-Pacific region. Outlook data is not provided in the input, but the company's revenue of 8.72 billion JPY in the latest period suggests a stable base. The absence of forward-looking guidance makes it difficult to assess growth trajectory, but the capital expenditure of 625.4 million JPY indicates ongoing investment in operations. The company's free cash flow is positive but modest, which may limit its ability to fund aggressive expansion. Risk factors include a medium liquidity risk and a key flag of negative net cash after subtracting total debt. The dilution risk is assessed as low, with no near-term pressure expected. The company's capital structure is stable, with long-term debt of 3.76 billion JPY and cash and equivalents of 1.87 billion JPY. No dilution sources are explicitly cited in the input, but the low dilution risk suggests no imminent equity issuance. Recent events include the latest financial filing, which shows a net income of 230.8 million JPY and an EPS of 28.50 JPY. No recent transcripts or filings beyond the financial snapshot are provided in the input, so no additional commentary on management guidance or strategic shifts is available.
Key takeaways
  • Fuji Seiki maintains a balanced capital structure with a debt-to-equity ratio of 1.01.
  • The company's return on equity of 6.23% is below the industry median, indicating underperformance in shareholder returns.
  • Free cash flow of 136.6 million JPY is positive but limited, which may constrain growth initiatives.
  • The company's liquidity position is characterized as medium risk, with a current ratio of 1.39.
  • No near-term dilution pressure is expected, and the dilution risk is assessed as low.
  • The company's operations are likely concentrated in the Asia-Pacific region, with no geographic breakdown provided.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$8.72B
Gross profit$1.80B
Operating income$424.3M
Net income$230.8M
R&D
SG&A
D&A
SBC
Operating cash flow$927.9M
CapEx-$625.4M
Free cash flow$136.6M
Total assets$9.80B
Total liabilities$6.09B
Total equity$3.70B
Cash & equivalents$1.87B
Long-term debt$3.76B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.70B
Net cash-$1.88B
Current ratio1.4
Debt/Equity1.0
ROA2.4%
ROE6.2%
Cash conversion4.0%
CapEx/Revenue-7.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Goods · cohort 13 companies
Metric6400Activity
Op margin4.9%9.4% medp25 9.4% · p75 9.4%bottom quartile
Net margin2.6%5.8% medp25 5.8% · p75 5.8%bottom quartile
Gross margin20.7%26.9% medp25 26.9% · p75 26.9%bottom quartile
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue-7.2%2.4% medp25 1.6% · p75 3.3%bottom quartile
Debt / equity101.0%106.4% medp25 106.4% · p75 106.4%bottom quartile
Observations
IR observations
Last actual EPS28.50 JPY
Last actual revenue8,719,260,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 18:20 UTC#84cfe0a4
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 18:21 UTCJob: 30643673